The connection between the loss of E-cadherin and the gain of vimentin expression by cancer cells has been established by many studies (12) and has been associated with the development of invasive cancer, metastatic dissemination, and poor clinical prognosis in various human tumors (8) including thyroid carcinomas (13, 14). The gene discussed is CDH1; the disease is thyroid gland carcinoma.